Pancreatic Cancer Research

ResearcherJohns Hopkins UniversityActive in the last 2 years

Chunhui Yuan

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-1496-8592; OpenAlex author ID A5101797076. Sources: OpenAlex.

Their work

Papers
17 (first author 0, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
67
Papers, trials and grants by year

2016: 3 papers · 2017: none · 2018: 2 papers · 2019: 4 papers · 2020: 1 paper · 2021: 2 papers · 2022: 2 papers · 2023: 2 papers · 2024: 1 paper

Papers 17

  1. Overcome the challenge for intratumoral injection of STING agonist for pancreatic cancer by systemic administration. Co-author DOI 10.1186/s13045-024-01576-z↗
  2. The expression characteristics of transmembrane protein genes in pancreatic ductal adenocarcinoma through comprehensive analysis of bulk and single-cell RNA se… Last author DOI 10.3389/fonc.2023.1047377↗
  3. Clinical characteristics, treatment patterns and survival outcomes of early-onset pancreatic adenocarcinoma: a population-based study. Last author PMID 36777821↗
  4. Should Positive Cytology Revealed by Intraoperative Lavage Preclude Radical Resection in Resectable Pancreatic Cancer?: A Systemic Review and Meta-analysis. Co-author DOI 10.1097/mpa.0000000000002163↗
  5. Preoperative Multiparametric Quantitative Magnetic Resonance Imaging Correlates with Prognosis and Recurrence Patterns in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3390/cancers14174243↗
  6. Challenges of the current precision medicine approach for pancreatic cancer: A single institution experience between 2013 and 2017. Co-author DOI 10.1016/j.canlet.2020.10.039↗
  7. Establishment of a Macrophage Phenotypic Switch Related Prognostic Signature in Patients With Pancreatic Cancer. Co-author DOI 10.3389/fonc.2021.619517↗
  8. Pancreatic ductal adenocarcinoma immune microenvironment and immunotherapy prospects. Co-author DOI 10.1016/j.cdtm.2020.01.002↗
  9. Metabolomics identifies serum and exosomes metabolite markers of pancreatic cancer. Co-author DOI 10.1007/s11306-019-1550-1↗
  10. Postoperative metastasis prediction based on portal vein circulating tumor cells detected by flow cytometry in periampullary or pancreatic cancer. Co-author DOI 10.2147/cmar.s210332↗
  11. Serum Derived Exosomes From Pancreatic Cancer Patients Promoted Metastasis: An iTRAQ-Based Proteomic Analysis. Co-author DOI 10.2147/ott.s229494↗
  12. [Pancreatic ductal adenocarcinoma immune microenvironment and immunotherapy prospects]. Last author DOI 10.3760/cma.j.issn.0529-5815.2019.01.003↗
  13. The prognostic value of B7-H4 in pancreatic cancer: Systematic review and meta-analysis. Co-author DOI 10.1097/md.0000000000010088↗
  14. G-CSF associates with neurogenesis and predicts prognosis and sensitivity to chemotherapy in pancreatic ductal adenocarcinoma. Co-author DOI 10.2147/cmar.s165226↗
  15. Neutrophils assist the metastasis of circulating tumor cells in pancreatic ductal adenocarcinoma: A new hypothesis and a new predictor for distant metastasis. Co-author DOI 10.1097/md.0000000000004932↗
  16. Prognostic significance of K-ras mutations in pancreatic cancer: a meta-analysis. Co-author DOI 10.1186/s12957-016-0888-3↗
  17. Preoperative neutrophil-to-lymphocyte ratio and tumor-related factors to predict lymph node metastasis in patients with pancreatic ductal adenocarcinoma (PDAC). Co-author DOI 10.18632/oncotarget.11031↗

Closest collaborators

The 25 strongest of 67 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Dianrong Xiu · 9 shared papers, 2016–2022 · strength 0.97
  2. Lingfu Zhang · 8 shared papers, 2016–2022 · strength 0.76
  3. Lianyuan Tao · 8 shared papers, 2016–2019 · strength 0.71
  4. Lei Zheng · 4 shared papers, 2019–2024 · strength 0.52
  5. Bin Jiang · 5 shared papers, 2016–2021 · strength 0.41
  6. Siqian Ren · 2 shared papers, 2023 · strength 0.37
  7. Chen Ye Ma · 2 shared papers, 2019–2023 · strength 0.35
  8. Nan Niu · 2 shared papers, 2020–2024 · strength 0.28
  9. Keyu Li · 2 shared papers, 2020–2024 · strength 0.28
  10. Alex B. Blair · 2 shared papers, 2021–2024 · strength 0.24
  11. Dianrong Xiu · 2 shared papers, 2019 · strength 0.23
  12. Gang Li · 1 shared paper, 2023 · strength 0.18
  13. Qing Chen · 1 shared paper, 2023 · strength 0.18
  14. Chen Ye · 1 shared paper, 2023 · strength 0.18
  15. Lei Li · 1 shared paper, 2022 · strength 0.17
  16. Bingqi Li · 1 shared paper, 2022 · strength 0.17
  17. Piaoe Zeng · 1 shared paper, 2022 · strength 0.16
  18. Chao Qu · 1 shared paper, 2022 · strength 0.16
  19. Huishu Yuan · 1 shared paper, 2022 · strength 0.16
  20. Mengni He · 1 shared paper, 2024 · strength 0.16
  21. Noelle R. Jurcak · 1 shared paper, 2024 · strength 0.16
  22. Xu-Bao Liu · 1 shared paper, 2024 · strength 0.16
  23. Brian T. Herbst · 1 shared paper, 2024 · strength 0.16
  24. Junke Wang · 1 shared paper, 2024 · strength 0.16
  25. Noah S Rozich · 1 shared paper, 2024 · strength 0.16

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.